Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Market capitalization of Biogen (BIIB)
Market cap: $43.23 Billion
As of May 2023 Biogen has a market cap of $43.23 Billion. This makes Biogen the world's 378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Biogen from 2004 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $43.23 B | 8.42% |
| 2022 | $39.87 B | 13.15% |
| 2021 | $35.24 B | -6.47% |
| 2020 | $37.67 B | -27.11% |
| 2019 | $51.69 B | -12.89% |
| 2018 | $59.34 B | -11.92% |
| 2017 | $67.37 B | 9.19% |
| 2016 | $61.69 B | -7.87% |
| 2015 | $66.96 B | -15.89% |
| 2014 | $79.62 B | 20.51% |
| 2013 | $66.07 B | 90.8% |
| 2012 | $34.62 B | 29.53% |
| 2011 | $26.73 B | 65.75% |
| 2010 | $16.12 B | 9.68% |
| 2009 | $14.70 B | 7.18% |
| 2008 | $13.71 B | -18.49% |
| 2007 | $16.83 B | 1.49% |
| 2006 | $16.58 B | 7.9% |
| 2005 | $15.36 B | -32.09% |
| 2004 | $22.63 B |
End of Day market cap according to different sources
On May 30th, 2023 the market cap of Biogen was reported to be:
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $401.16 B | 827.92% | 🇺🇸 USA |
 Pfizer PFE | $208.93 B | 383.27% | 🇺🇸 USA |
 AbbVie ABBV | $240.71 B | 456.80% | 🇺🇸 USA |
 Amgen AMGN | $116.76 B | 170.09% | 🇺🇸 USA |
 Sanofi SNY | $127.90 B | 195.85% | 🇫🇷 France |
 Gilead Sciences GILD | $95.21 B | 120.23% | 🇺🇸 USA |
 Illumina ILMN | $30.75 B | -28.87% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $14.89 M | -99.97% | 🇺🇸 USA |
 Qiagen QGEN | $10.32 B | -76.11% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | $11.21 B | -74.05% | 🇺🇸 USA |